Acasti Pharma reported $-3704000 in EBIT for its fiscal quarter ending in December of 2024.


Ebit Change Date
Acasti Pharma USD -3704000 1.13M Dec/2024
Addus HomeCare USD 32.89M 3.74M Jun/2025
Amarin USD -16755000 707K Mar/2025
Cassava Sciences USD -45392000 15.9M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Option Care Health USD 83.31M 4.12M Jun/2025
Organigram Holdings CAD -2105000 9.2M Jun/2025
Tilray USD -42218000 5.65M Nov/2024